Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
Journal of Pediatric Surgery|June 19, 2012
Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in childrenSaif F Hassan, Shawn Mathur, Thomas J Magliaro, et al.Scientific Reports|November 16, 2019
Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancerAdam J Camblin, Gege Tan, Michael D Curley, et al.Pancreas|June 17, 2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic CancerDavid Goldstein, Daniel D Von Hoff, E Gabriela Chiorean, et al.Research Square|April 25, 2024
Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for NeuroblastomaLi Che-Hsing, Sandhya Sharma, Andras A Heczey, et al.Cytotherapy|July 6, 2024
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges facedAshish O Gupta, Melissa Azul, Senthil Velan Bhoopalan, et al.Molecular Cancer Therapeutics|May 18, 2005
Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosisRoberto Tonelli, Stefania Purgato, Consuelo Camerin, et al.Blood|October 31, 2008
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsChrystal U Louis, Karin Straathof, Catherine M Bollard, et al.Angiogenesis|April 13, 2011
Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastomaDanielle M Patterson, Dongbing Gao, Denae N Trahan, et al.Nature Medicine|February 17, 2025
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastomaChe-Hsing Li, Sandhya Sharma, Andras A Heczey, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinomaChrystal U Louis, Karin Straathof, Catherine M Bollard, et al.Pageof 8